ALBANY, New York, November 2, 2016 /PRNewswire/ -- The global market for advanced wound care management, being a highly technology- and research- oriented specialty sector of the overall wound care market, features few companies and a highly consolidated competitive landscape, observes a recent report by Transparency Market Research. The top four vendors in the market, namely Molnlycke Health Care, Smith and Nephew plc, Convatec, and Acelity L.P. Inc., accounted for a share of nearly 65% of the global market in 2015. The market is highly competitive in terms of product pricing and the rate of introduction of new product varieties. Transparency Market Research estimates that the advanced wound care management market will expand at a CAGR of 6.3% from 2016 to 2024 and rise from a valuation of at US$6,457.0 mn in 2015 to US$11,161.6 mn by 2024. Download PDF Brochure of Research Insights:http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16139Market in Asia Pacific to Exhibit Promising Growth Based on product type, advanced wound care dressings was the dominant segment of the global advanced wound care management market, accounting for a share of nearly 62.4% of the overall market in 2015. In terms of geography, North America dominated with a 42.6% of the market in the said year. Rising Geriatric Population to Stoke Demand for Effective Products Increasing prevalence of lifestyle diseases and disorders is leading to the increased prevalence of chronic wounds such as venous leg ulcer, diabetic foot ulcer, and pressure ulcer globally. As chronic wounds generally take longer to heal and levy vast socioeconomic burdens on any society, the demand for advanced wound care therapies for their effective treatment is rising globally. Diabetic ulcers are growing rapidly due to the increased incidence of both type I and maturity-onset diabetes in developed as well as developing economies across the world. The prevalence of diabetic ulcers is rising at 9% annually, which is much faster than the rate of development of new treatment technologies. Currently, there are over 4.5 million pressure ulcer patients in the world that require treatment every year. Moreover, there are more than 9.7 million venous ulcers and approximately 10 million diabetic ulcers patients in the world that require treatment.